572 related articles for article (PubMed ID: 26467042)
21. [Cadherins E and P expression in the molecular types of breast cancer].
Fernández Á; Reigosa A; Caleiras E; Saldivia F; Hardisson D; Sanz F
Invest Clin; 2015 Jun; 56(2):155-68. PubMed ID: 26299056
[TBL] [Abstract][Full Text] [Related]
22. Expression of EMT Markers SLUG and TWIST in Breast Cancer.
Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
[TBL] [Abstract][Full Text] [Related]
24. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course.
Jia W; Zhu J; Martin TA; Jiang A; Sanders AJ; Jiang WG
Anticancer Res; 2015 May; 35(5):2635-43. PubMed ID: 25964539
[TBL] [Abstract][Full Text] [Related]
26. HER2 expression is a strong independent predictor of nodal metastasis in breast cancer.
Ahmed AR
J Egypt Natl Canc Inst; 2016 Dec; 28(4):219-227. PubMed ID: 27756653
[TBL] [Abstract][Full Text] [Related]
27. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer.
Jang MH; Kim HJ; Gwak JM; Chung YR; Park SY
Hum Pathol; 2017 Oct; 68():69-78. PubMed ID: 28882698
[TBL] [Abstract][Full Text] [Related]
30. Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options.
Burnett JP; Korkaya H; Ouzounova MD; Jiang H; Conley SJ; Newman BW; Sun L; Connarn JN; Chen CS; Zhang N; Wicha MS; Sun D
Sci Rep; 2015 Nov; 5():15821. PubMed ID: 26522776
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
32. IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.
Samanta S; Sun H; Goel HL; Pursell B; Chang C; Khan A; Greiner DL; Cao S; Lim E; Shultz LD; Mercurio AM
Oncogene; 2016 Mar; 35(9):1111-21. PubMed ID: 25982283
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
34. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
[TBL] [Abstract][Full Text] [Related]
35. [Expressions of epithelial cell adhesion molecule, vimentin and N-cadherin in molecular subtypes of breast cancer and the correlation among them].
Fu L; Liu M; Yu X; Li X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1137-1142. PubMed ID: 27932757
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
38. SALL4 promotes tumor progression in breast cancer by targeting EMT.
Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC
Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442
[TBL] [Abstract][Full Text] [Related]
39. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
